NuSirt Sciences is a biotechnology company focused on developing products targeting metabolic diseases associated with over-nutrition such as obesity, diabetes, and inflammatory stress. The company has developed a breakthrough technology platform that combines natural compounds with various pharmaceutical agents. NuSirts first product, NS-0100, uses NuSirts platform technology to combine the natural product leucine with a very low dose of metformin for the treatment of type II diabetes. Although, metformin is the gold standard in the treatment of early-type II diabetes many patients can not tolerate the adverse gastrointestinal side effects metformin can cause in some patients. The company is currently testing varying doses of NS-0100 in Phase 2 clinical study to find the most efficacious dose of this new combination. If NuSirts clinical trials are successful NS-0100 may offer patients a viable alternative to metformin. NuSirt has filed eleven patent applications (two of which have been issued) and completed four clinical and numerous pre-clinical studies based on the patented technologies.

Since its founding in 2006, Escape Therapeutics has dedicated itself to transforming healthcare through discovery, development, and commercialization of innovative stem cell-based curative therapeutics capable of relieving the suffering of children and adults inflicted with devastating diseases or injuries that are currently inadequately treated and/or incurable.

BioRestorative Therapies is a development stage company, develops medical procedures using cell and tissue protocols, primarily involving adult stem cells, designed for patients to undergo minimally invasive cellular-based treatments. The company focuses on the development of the ThermoStem Program that engages in the use of brown fat in connection with the cell-based treatment of Type 2 diabetes, obesity, hypertension, other metabolic disorders, and cardiac deficiencies, as well as is involved in the study of stem cells, several genes, proteins, and/or mechanisms, which are related to these diseases and disorders. It also focuses on the development of brtxDISC (Disc Implanted Stem Cells) Program for the adult stem cell treatment of disc and spine conditions, including bulging and herniated discs.

CURNA, Inc. was engaged in manufacturing pharmaceutical products. The company was headquartered in Jupiter, FL.

Sk Bioland Co. Ltd., part of SKC Co., Ltd., is a South Korean company focused on perfumes, cosmetics, and other toilet preparations.

NH Foods Ltd. engages in the business of meat processing and packing services. Its operations carried out through the following segments: Fresh Meat, Processed Food, Marine Products, Dairy Products, and Others. The Fresh Meat segment provides consistently and quickly supply safe, high-quality, and fresh meat. The Processed Food segment provides food products such as ham & sausages, deli & processed foods, and others. The Marine Products segment provides safe & secure raw marine ingredients, and processed marine products from Japan and abroad. The Dairy Products segment delivers the authentic taste of cheese to more consumers, and also engages in the commercial cheese marketing, supplying bakeries, confectionary makers, and convenience store chains. The Others segment engages in the business of freeze-dried foods, meat extracts, health foods, trading, sports and information technology services. The company was founded by Yoshinori Okoso in March 1942 and is headquartered in Osaka, Japan.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Nestec SA, a subsidiary of Nestlé SA, is a Swiss company located in Vevey. The firm manufactures nutrition food products.

Shanghai Shengshi Biomedical Technology Co., Ltd., established on 2018-02-24, Business scope includes biomedical technology,Technology development in health technology,Technical Services,technology transfer,technical consulting,New functional material technology promotion service,Fitness Equipment,cosmetic,Sales of daily necessities,Graphene material,Research and development of graphite and carbon products,Sales,Engaged in the import and export of goods and technology,Business Consulting,food sales,Medical device management. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Shanghai Bode Gene Development Co., Ltd., established on 1998-03-22, Business scope includes bioengineering,Technology transfer in the field of genetic engineering expertise,technology development,technical consulting,Technical services and manufacture of related reagents and equipment,Sales;Bioengineering and Genetic Engineering Products,electronics,Chemical Products(In addition to dangerous goods)import and export business. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Syndax Pharmaceuticals is a clinical-stage pharmaceutical company that focuses on an HDAC inhibitor for solid tumors and hematological tumors. It offers therapies to treat solid tumors and lung, breast, and hematological cancer. The company is developing axatilimab, a monoclonal antibody that blocks the colony-stimulating factor 1 (CSF-1) receptor, in development for chronic Graft versus Host Disease, and entinostat, a class I HDAC inhibitor. Syndax Pharmaceuticals pipeline includes and SNDX-5613, a highly selective inhibitor of the Menin–MLL binding interaction, in development for the treatment of patients with MLLr and NPM1 acute leukemias.

Saiye (Suzhou) Biotechnology Co., Ltd, established on 2011-05-27, Business scope includes bioengineering technology development,technical consulting,technology transfer,Technical Services,Research and development of biomedical materials and products;Distribution of experimental equipment;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Guangzhou Jiankun Biotechnology Co., Ltd., established on 2011-10-26, Business scope includes biotechnology development services;Biotechnology Consulting,communication service;Biotechnology Transfer Services;Import and export(Excluding franchised products);Technology Import and Export;Commodity wholesale trade(Except for licensed and approved products);Commodity retail trade(Except for licensed and approved products);Retailing of cosmetics and hygiene products;Wholesale of cosmetics and hygiene products;

Hospices Civils de Lyon provides health care services. It operates facilities including various predominantly general facilities that offers emergency, medical and surgical services in a wide range of disciplines, specialist facilities and four geriatric facilities. The company is headquartered in Lyon, France.

Part of ICD International Cosmetic Development SA, Orlane SASU is a company headquartered in Paris, France. The firm retails cosmetics and perfumes. It was founded in 1985.